Could a single infusion transform a patient’s own T cells into cancer-fighting machines? Researchers are betting on single-stranded DNA and lipid nanoparticles to make in vivo CAR-T a scalable reality.
3
min read
Newsletters
Receive the latest pharmaceutical news, personalities, education, and career development – weekly to your inbox.